Example 24
Off-target binding of multivalent HER3-specific Nanobodies with HLE was assessed by measuring their binding capacity to Fc-HER1 (R&D Systems, 344-ER), Fc-HER2 (R&D Systems, 1129-ER) and Fc-HER4 (R&D Systems, 1131-ER) coated on ELISA plates. Serial dilutions of the Nanobodies starting at a concentration of 500 nM were tested and detection was done using the biotinylated ALB-specific Nanobody 02H05 and streptavidin-HRP (Dako, P0397). Binding to Fc-HER3 (R&D Systems, 348-RB) was used as positive control for the HER3-specific Nanobodies. The polyclonal antibodies anti-HER1 (R&D Systems, AF231), anti-HER2 (R&D Systems, AF1129), anti-HER3 (R&D Systems, AF234) and anti-HER4 (R&D Systems, AF1131) were used as quality control of the HER coating on the plates. The results in